ZA973653B - Pharmaceutical compositions. - Google Patents
Pharmaceutical compositions.Info
- Publication number
- ZA973653B ZA973653B ZA9703653A ZA973653A ZA973653B ZA 973653 B ZA973653 B ZA 973653B ZA 9703653 A ZA9703653 A ZA 9703653A ZA 973653 A ZA973653 A ZA 973653A ZA 973653 B ZA973653 B ZA 973653B
- Authority
- ZA
- South Africa
- Prior art keywords
- surfactant
- propylene glycol
- range
- chain length
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9608719.2A GB9608719D0 (en) | 1996-04-26 | 1996-04-26 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA973653B true ZA973653B (en) | 1997-11-19 |
Family
ID=10792737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9703653A ZA973653B (en) | 1996-04-26 | 1997-04-25 | Pharmaceutical compositions. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0904064B1 (pt) |
JP (1) | JP5088804B2 (pt) |
KR (1) | KR100511133B1 (pt) |
AT (1) | ATE207346T1 (pt) |
AU (1) | AU2707497A (pt) |
DE (1) | DE69707669T2 (pt) |
DK (1) | DK0904064T3 (pt) |
ES (1) | ES2164339T3 (pt) |
GB (1) | GB9608719D0 (pt) |
PT (1) | PT904064E (pt) |
WO (1) | WO1997040823A1 (pt) |
ZA (1) | ZA973653B (pt) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2777784B1 (fr) * | 1998-04-27 | 2004-03-19 | Arepa | Composition pharmaceutique a base d'estrogene et de progesterone |
US20040234472A1 (en) | 2001-04-20 | 2004-11-25 | Jackson John K. | Micellar drug delivery systems for hydrophobic drugs |
US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
CA2363842C (en) | 1999-02-26 | 2006-01-10 | Shionogi & Co., Ltd. | Chewable soft capsule having improved ingestion property and method for producing the same |
NZ514290A (en) * | 1999-04-01 | 2003-08-29 | Akzo Nobel Nv | Formulation comprising testosterone undecanoate and castor oil |
GB9907715D0 (en) * | 1999-04-01 | 1999-05-26 | Scherer Corp R P | Pharmaceutical compositions |
US6652880B1 (en) | 1999-04-01 | 2003-11-25 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
JP2004505996A (ja) * | 2000-08-10 | 2004-02-26 | デルシス ファーマシューティカル コーポレイション | 疎水性薬剤を有する改良された固形の製薬的投薬配合物 |
FR2818905A1 (fr) * | 2000-12-28 | 2002-07-05 | Cll Pharma | Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile |
EE200400024A (et) | 2001-06-21 | 2004-06-15 | Pfizer Products Inc. | Kolesterüülestri ülekandevalgu inhibiitorite iseemulgeeruvad formulatsioonid |
WO2003002095A1 (fr) * | 2001-06-28 | 2003-01-09 | Chugai Seiyaku Kabushiki Kaisha | Preparation d'une micro-emulsion de type huile-eau |
FR2832065B1 (fr) * | 2001-11-13 | 2004-11-05 | Besins Int Belgique | Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations |
JO2505B1 (en) | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | Pharmacy methods and formulations for obtaining acceptable serum testosterone levels |
CN1299686C (zh) * | 2003-04-03 | 2007-02-14 | 上海医药工业研究院 | 黄体酮半固体骨架制剂的组合物 |
BRPI0409585A (pt) * | 2003-04-17 | 2006-04-18 | Boehringer Ingelheim Int | suplemento multivitamìnico e mineral para mulheres grávidas |
JP2005047851A (ja) * | 2003-07-29 | 2005-02-24 | Nisshin Pharma Inc | ユビデカレノン含有組成物 |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
PT1530965E (pt) | 2003-11-11 | 2006-05-31 | Udo Mattern | Sistema de administracao de libertacao controlada de hormonas sexuais para aplicacao nasal |
AU2006236564B2 (en) | 2005-04-15 | 2011-02-17 | Tolmar, Inc. | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
CN101600417B (zh) | 2006-10-04 | 2012-05-30 | M&P专利股份公司 | 用于神经递质的经鼻施用的控制释放递送系统 |
EP1961412A1 (en) * | 2006-12-27 | 2008-08-27 | LEK Pharmaceuticals D.D. | Self-microemulsifying drug delivery systems |
GB0807605D0 (en) * | 2008-04-28 | 2008-06-04 | Diurnal Ltd | Lipid composition |
AU2014200332B2 (en) * | 2008-04-28 | 2016-10-06 | Diurnal Limited | Lipid composition |
US8309107B2 (en) | 2008-10-06 | 2012-11-13 | Banner Pharmacaps, Inc. | Stable solutions of orlistat for pharmaceutical dosage forms |
PL2351566T3 (pl) | 2008-10-22 | 2015-06-30 | Santen Pharmaceutical Co Ltd | Kompozycja farmaceutyczna o ulepszonym wchłanianiu przez układ pokarmowy |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
US9011908B2 (en) | 2009-04-06 | 2015-04-21 | Banner Life Sciences Llc | Progesterone solutions for increased bioavailability |
EA201290315A1 (ru) * | 2009-11-09 | 2012-10-30 | Кэпсьюджел Белджиум Нв | Носитель для доставки |
PL2519230T3 (pl) * | 2009-12-31 | 2019-05-31 | Marius Pharmaceuticals Llc | Modulacja rozpuszczalności, stabilności, absorpcji, metabolizmu i profilu farmakokinetycznego leków lipofilowych przez sterole |
CN103705462B (zh) * | 2010-04-12 | 2016-08-31 | 克劳拉斯医疗有限公司 | 口服睾酮酯制剂以及包含其的治疗睾酮缺乏症的方法 |
RU2012142997A (ru) * | 2010-04-12 | 2014-06-20 | Кларус Терапеутикс, Инк. | Оральные фармацевтические композиции сложных эфиров тестостерона и способы лечения недостатка тестостерона с их использованием |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US8900631B2 (en) | 2011-04-28 | 2014-12-02 | Health Science Funding, LLC | Dosage form to increase prasterone bioavailability |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
FR2988609B1 (fr) * | 2012-03-30 | 2015-09-04 | Commissariat Energie Atomique | Formulation pour l'hormonotherapie |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
RU2740059C2 (ru) | 2012-06-18 | 2020-12-31 | Терапьютиксмд, Инк. | Капсулы с растворимым эстрадиолом для интравагинального введения |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
FR2997627B1 (fr) | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant de l'ulipristal acetate |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
WO2014143127A1 (en) | 2013-03-15 | 2014-09-18 | Differential Drug Development Associates Llc | Emulsion formulations |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
KR20170020779A (ko) * | 2014-06-17 | 2017-02-24 | 머크 샤프 앤 도메 비.브이. | 테스토스테론 운데카노에이트의 안정한 제제 |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017105512A1 (en) * | 2015-12-18 | 2017-06-22 | Proinvet Innovations S.A. | Formulations and methods for controlling the reproductive cycle and ovulation |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
WO2017173191A1 (en) * | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
AU2017239679A1 (en) * | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
EP3544614A4 (en) | 2016-11-28 | 2020-08-05 | Lipocine Inc. | ORAL TESTOSTERONE UNDECANOATE THERAPY |
KR20200093008A (ko) | 2017-11-27 | 2020-08-04 | 유메크린 코그니션 에이비 | 3α-에티닐-3β-하이드록시안드로스탄-17-온 옥심의 약학적 제형 |
EP3950071A4 (en) * | 2019-03-29 | 2022-12-28 | Sekisui Chemical Co., Ltd. | CORE-SHELL STRUCTURE, MANUFACTURE, EXTERNAL MEDICATION, TAPE AND COSMETIC PRODUCT |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
WO2023057626A1 (en) | 2021-10-08 | 2023-04-13 | Chemo Research, S.L. | Oral pharmaceutical compositions of progesterone and estradiol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
-
1996
- 1996-04-26 GB GBGB9608719.2A patent/GB9608719D0/en active Pending
-
1997
- 1997-04-25 ZA ZA9703653A patent/ZA973653B/xx unknown
- 1997-04-28 JP JP53867897A patent/JP5088804B2/ja not_active Expired - Lifetime
- 1997-04-28 AT AT97920854T patent/ATE207346T1/de active
- 1997-04-28 AU AU27074/97A patent/AU2707497A/en not_active Abandoned
- 1997-04-28 DK DK97920854T patent/DK0904064T3/da active
- 1997-04-28 KR KR1019980708569A patent/KR100511133B1/ko not_active IP Right Cessation
- 1997-04-28 WO PCT/GB1997/001247 patent/WO1997040823A1/en not_active Application Discontinuation
- 1997-04-28 DE DE69707669T patent/DE69707669T2/de not_active Expired - Lifetime
- 1997-04-28 EP EP97920854A patent/EP0904064B1/en not_active Expired - Lifetime
- 1997-04-28 ES ES97920854T patent/ES2164339T3/es not_active Expired - Lifetime
- 1997-04-28 PT PT97920854T patent/PT904064E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
KR100511133B1 (ko) | 2006-04-28 |
ATE207346T1 (de) | 2001-11-15 |
GB9608719D0 (en) | 1996-07-03 |
EP0904064B1 (en) | 2001-10-24 |
DK0904064T3 (da) | 2001-12-17 |
DE69707669T2 (de) | 2002-07-11 |
KR20000065025A (ko) | 2000-11-06 |
DE69707669D1 (de) | 2001-11-29 |
EP0904064A1 (en) | 1999-03-31 |
AU2707497A (en) | 1997-11-19 |
ES2164339T3 (es) | 2002-02-16 |
JP5088804B2 (ja) | 2012-12-05 |
PT904064E (pt) | 2002-02-28 |
WO1997040823A1 (en) | 1997-11-06 |
JP2000510458A (ja) | 2000-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA973653B (en) | Pharmaceutical compositions. | |
US5532002A (en) | Gelatin pharmaceutical formulations | |
US5738871A (en) | Pharmaceutical formulations | |
CA2366754A1 (en) | Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants | |
KR940018091A (ko) | 불포화 지방산을 포함하는 처방 | |
NZ512287A (en) | Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester | |
UY26303A1 (es) | Composiciones farmacéuticas para administración oral y tópica | |
IL143604A0 (en) | Dispersable concentrate for the delivery of cyclosporin | |
RU98105629A (ru) | Препараты, содержащие циклоспорин, в виде капсул с мягким покрытием | |
SI9720010B (sl) | Ciklosporin vsebujoči mehki kapsulni pripravki | |
AU4554597A (en) | Formulations for topical use | |
JPH11199493A (ja) | 皮膚外用剤組成物 | |
IL122434A (en) | Compositions of mixed colloidal particles in an aqueous environment for sustained delivery of bioactive agents and pharmaceutical preparations therewith | |
MY130474A (en) | Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants | |
RU99106544A (ru) | Косметическая композиция |